Expert Opinion on Drug Delivery

Papers
(The TQCC of Expert Opinion on Drug Delivery is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
How can nanoemulsions be used for photosensitizer drug delivery?104
A tale of nucleic acid–ionizable lipid nanoparticles: Design and manufacturing technology and advancement77
Calcium phosphate coated nanoparticles for drug delivery: where are we now?75
Challenges and opportunities in neurometabolic disease treatment with enzyme delivery70
Dose accuracy of the follitropin alfa pen injector 2.0, the follitropin alfa:lutropin alfa 2:1 combination pen injector 2.0 and the choriogonadotropin alfa pen injector 1.0 used for fertility treatmen64
Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges60
Receptor-mediated nose-to-brain delivery of drug combination-loaded polymeric nanocarriers for the treatment of glioblastoma- current progress and future perspectives part II: polymeric nanocarriers f57
An update on the port delivery system with ranibizumab for retinal diseases57
Theranostic metallic nanoconjugates for colorectal cancer: targeting strategies, imaging modalities, and translational challenges56
The quest to deliver high-dose rifampicin: can the inhaled approach help?54
Brain delivery enabled by transient blood–brain barrier disruption induced by regadenoson: a PET imaging study53
Needle-free injection of basal insulin improves fasting glucose variability as assessed by continuous glucose monitoring in T2DM: a prospective randomized multicenter open-label crossover study51
All eyes on semifluorinated alkanes: a comprehensive review of the influence of semifluorinated alkane eyedrops on tear film stabilization and drug delivery in dry eye disease50
Artificial Intelligence’s role in colon-targeted drug delivery49
Iontophoresis for the cutaneous delivery of nanoentraped drugs48
Assessment of adherence to, and persistence with, an electromechanical autoinjector for subcutaneous interferon beta-1a injections for multiple sclerosis treatment over 3 years47
Enhanced skin drug delivery using dissolving microneedles: a potential approach for the management of skin disorders44
Nanominerals: a multifaceted biomaterial for regenerative medicine and drug delivery42
Pre-ANDA strategy and Human Factors activities to de-risk pharmaceutical companies ANDA submission of drug–device combination products: case study of a formative Comparative Use Human Factors study40
Nuclear medicine imaging methods as novel tools in the assessment of pulmonary drug disposition39
Current insights into polymeric micelles for nasal drug delivery39
How can we optimize the delivery of IL-2 to traumatic brain injury patients?38
Self-assembled structures of ascorbic acid derivatives: encapsulation properties and controlled drug delivery applications37
Hydrophobic ion pairing-based self-emulsifying drug delivery systems: a new strategy for improving the therapeutic efficacy of water-soluble drugs36
Do the chitosan nanoparticles really augment the drugs’ transdermal fluxes: ending the debate using meta-analysis35
Progress and potential of nanobubbles for ultrasound-mediated drug delivery35
Small patients, big challenges: navigating pediatric drug manipulations to prevent medication errors - a comprehensive review34
Recent advances in the use of liquid crystalline nanoparticles for non-small cell lung cancer treatment34
Engineering polycaprolactone nanowires for pharmacologic efficacy34
Current status and prospect for future advancements of long-acting antibody formulations33
Innovative insight into the mechanism of enantioselective skin permeation for chiral drugs33
Future applications of self-immolative polymers in drug delivery33
Ferulic acid’s therapeutic odyssey: nano formulations, pre-clinical investigations, and patent perspective32
Oral administration of M13-loaded nanoliposomes is safe and effective to treat colitis-associated cancer in mice32
Continuous subcutaneous levodopa-carbidopa for the treatment of advanced Parkinson’s disease: is it an improvement on other delivery?32
Mechanistic and translational frontiers on “VEGF and TKI inhibitor axitinib” : unfolding drug delivery approaches and opportunities in cancer therapy32
Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms31
Magnetoliposomes for nanomedicine: synthesis, characterization, and applications in drug, gene, and peptide delivery31
Peptide amphiphile nanofibers: advanced drug delivery platforms for cardiovascular therapeutics31
A randomized crossover study assessing critical errors, preferences, and ease of use of two multidose powder inhalers31
Penetration enhancer–containing vesicles (PEVs): from deformable liposomes to barrier-modulating delivery platforms across multiple administration routes30
Are stimuli-responsive hybrid copolymer nanoparticles the next innovation in tumor drug delivery?29
Calcium carbonate in drug delivery: functional carrier design, applications, and data-driven perspectives29
Critical review on the role of excipient properties in pharmaceutical powder-to-tablet continuous manufacturing29
Acetalated dextran: a novel delivery platform for particle-based vaccines29
What role might nanolipogels play in enhancing drug delivery?28
How might intraluminal drug-delivery strategies be improved to enhance arteriovenous fistula maturation and patency?28
The potential public health benefit of live-attenuated pertussis vaccines27
Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices27
Solvent-exchange-based in situ forming implants: advances and challenges as long-lasting formulations26
Can radiopharmaceuticals be delivered by quantum dots?26
Potential bladder cancer therapeutic delivery systems: a recent update26
Differential targeting of olfactory epithelium and respiratory epithelium in nose-to-brain drug delivery25
Current insights into drug-coated balloons for peripheral arterial disease25
3D printed dosage forms, where are we headed?25
Bacterial and bacterial derivatives-based drug delivery systems: a novel approach for treating central nervous system disorders25
Silica nanoparticles for brain cancer25
Emerging landscape of bioinformatics and artificial intelligence applications in cell-penetrating peptide-based delivery23
Intramuscular injection of palmitic acid-conjugated Exendin-4 loaded multivesicular liposomes for long-acting and improving in-situ stability23
Synthesis of a targeted, dual pH and redox-responsive nanoscale coordination polymer theranostic against metastatic breast cancer in vitro and in vivo23
Cyclodextrin-based carriers for targeted drug delivery23
Laser microporation facilitates topical drug delivery: a comprehensive review about preclinical development and clinical application23
An overview of oral bioavailability enhancement through self-emulsifying drug delivery systems23
Understanding the interaction forces between shield-triggered autoinjectors and skin: an in-depth noninvasive study23
Platelets for advanced drug delivery in cancer22
Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: recent advances, emerging technologies, and development challenges22
A technology evaluation of the atypical use of a CPP-containing peptide in the formulation and performance of a clinical botulinum toxin product22
Dimeric ferulic acid conjugate as a prodrug for brain targeting after nasal administration of loaded solid lipid microparticles22
Treating glioblastoma with dextrin-based polymers22
Advancing the current state of gene therapies using adeno-associated virus vectors to treat atrial cardiomyopathy22
Topical film-forming systems for antifungal delivery: emerging strategies and in-depth evaluation22
Future applications of cyclic antimicrobial peptides in drug delivery21
Lipid-based nanosystems for wound healing21
Targeted transport of biotherapeutics at the blood-brain barrier21
Polyphosphoester cubosomes: introducing a novel drug delivery system21
Untethered shape-changing devices in the gastrointestinal tract21
Recent advances in antibacterial nanoformulations for endodontic applications21
Pediatric inhalation therapy and the aerodynamic rationale for age-based aerosol sizes21
Is electroporation the key to drug delivery in drug-resistant cancers?21
Microneedles for oral mucosal delivery – Current trends and perspective on future directions20
Smart delivery systems for magnetic hyperthermia: the role of thermoresponsive drug delivery20
Metered dose inhalers in the transition to low GWP propellants: what we know and what is missing to make it happen19
Particle surface coating for dry powder inhaler formulations19
Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood–brain barrier19
Evaluating the breadth of nucleic acid-based payloads delivered in lipid nanoparticles to establish fundamental differences in development19
Development and approval of novel injectables: enhancing therapeutic innovations19
Polymer-based thermoresponsive hydrogels for controlled drug delivery19
Inhalation delivery of nucleic acid gene therapies in preclinical drug development19
Biphasic drug release from electrospun structures18
An evolving perspective on novel modified release drug delivery systems for inhalational therapy18
3D-printed solid oral dosage forms for mental and neurological disorders: recent advances and future perspectives18
Drug and stem cells delivery to salivary glands – a concise review18
Opportunities for enteral drug delivery for neonates, infants, and toddlers: a critical exploration18
Recent advances in drug delivery to the central nervous system by inhalation18
Targeted delivery of therapeutics to the heart with calcium phosphate nanoparticles18
Where do we stand now regarding protein nanoparticles? Perspectives from the Six Thinking Hats framework17
Dendrimer-mediated targeting of angiogenic biomarkers: therapeutic intervention against cancer17
The engineering challenges and opportunities when designing potent ionizable materials for the delivery of ribonucleic acids17
Sustained release of brimonidine from conjunctival sac insert to reduce intraocular pressure for glaucoma treatment17
Drug delivery improvements to enable a flexible care setting for monoclonal antibody medications in oncology - Analogue-based decision framework16
Drug delivery and formulation development of hesperidin: a systematic review16
Targeting cerebral diseases with enhanced delivery of therapeutic proteins across the blood-brain barrier16
Correction16
The impact of common pharmaceutical excipients on the gut microbiota16
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part I – composition and production methods16
An interview with professor Dermot O’Toole by Zoe Kenney, commissioning editor16
Infusion-based drug delivery to the brain: what’s next?16
Redox chemical delivery system: an innovative strategy for the treatment of neurodegenerative diseases15
Inhaled antifungal therapy: benefits, challenges, and clinical applications15
Targeting the gut microbiome to control drug pharmacomicrobiomics: the next frontier in oral drug delivery15
An update on the latest strategies in retinal drug delivery15
Optimizing deferoxamine delivery through the skin for pressure ulcers15
Nano-drug delivery system of natural products for disease prevention and treatment14
GPP-TSAIII nanocomposite hydrogel-based photothermal ablation facilitates melanoma therapy14
Development of ROS-responsive liposomes toward targeted drug delivery14
Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities14
Redox responsive cyclodextrin-based drug delivery systems: a special insight to glutathione responsive CD-nanosponges14
Recent advances in microneedle technology in transdermal drug delivery systems14
Explicit analysis of in vivo , meterological and statistical hurdles in successful clinical translation of targeted nanomedicines and plausible remedial 14
Biodegradable nanoplatforms for antigen delivery: part II – nanoparticles, hydrogels, and microneedles for cancer immunotherapy14
A fluid and particle mechanics perspective of nasal drug delivery14
Engineering trafficking pathways to overcome immunosuppressive barriers in solid tumor immunotherapy14
Recent developments in nanofiber-based fast-disintegrating drug delivery systems14
Advanced nano-delivery systems in H. pylori eradication: targeting, efficacy, and clinical translation13
Mucoadhesive drug delivery systems: a promising noninvasive approach to bioavailability enhancement. Part II: formulation considerations13
Oncofetal chondroitin sulfate in cancer therapy: a promising target for anti-tumor drug delivery?13
Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence13
The current paradigm for biologic initiation: a confirmatory quantitative analysis of self-injection training practices13
Subunit antigen delivery: emulsion and liposomal adjuvants for next-generation vaccines13
Recent advances in nanoformulation development of Ritonavir, a key protease inhibitor used in the treatment of HIV-AIDS13
Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics13
Breast cancer epidemiology, diagnostic barriers, and contemporary trends in breast nanotheranostics and mechanisms of targeting13
Future outcomes and current limitations of injectable implants for vocal fold scarring13
Biomaterials-assisted construction of neoantigen vaccines for personalized cancer immunotherapy13
Rethinking probiotic delivery: new hope for preventing necrotizing enterocolitis13
Solid lipid nanoparticles: a promising tool for insulin delivery13
0.31106996536255